Environmental and genetic factors influencing inhibitor development.

Abstract excerpt

Inhibitor formation occurs at a frequency of 20% to 30% in severe hemophilia A, and 3% in hemophilia B. Today, it represents the major complication in patient care and renders classical substitution therapy ineffective. Genetic factors, such as factor VIII (FVIII) gene mutations and immune response genes, particularly the major histocompatibility complex, have been shown to constitute decisive risk factors for...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antibodies
• Share to Blood Coagulation Factor Inhibitors